Atypical Pneumonia

December 6, 2024 updated by: Aya Gamal hussein, Assiut University

Clinico Laboratory Study of Unresolving Pneumonia in Children

The goal of this observational study is to learn about causes of unresolved pneumonia in children who take appropriate antimicrobial therapy.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

Recurrent pneumonia is defined as two episodes of pneumonia in 1 year or three episodes over any time frame. Non resolving pneumonias are characterized by the persistence of symptoms and roentgenographic abnormalities for more than 1 month. The key step in evaluating the patient referred for recurrent or persistent pneumonia is to review the clinical and radiographic features of the episodes to determine if there is adequate documentation to proceed with treatment. After deciding that a patient has had a persistent episode of pneumonia or the requisite number of recurrent episodes of pneumonia (accompanied by radiographic evidence of pulmonary infiltrates), it is essential to classify the episodes into those involving single or multiple lobes. On the basis of this classification.

Study Type

Observational

Enrollment (Estimated)

45

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Aya Gamal Hussein, Resident doctor
  • Phone Number: 01060617625 800-555-5555
  • Email: yoyo74031@gmail.com

Study Locations

  • Egypt
      • Assiut, Egypt
        • Pediatrics hospital AssiutUniversity

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Children included in the definition of unresolving pneumonia

Description

Inclusion Criteria:

  • Patients with incomplete resolution by 4 weeks despite appropriate antimicrobial therapy.

    • From the age of one month to the age of 6 years old.

Exclusion Criteria:

  • *Age of the patient below one month and above 6 years old.

    • Patients with chronic lung diseases.
    • Patients with immunodeficiency.
    • Patient with aspiration pneumonia.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
studying the prevalence of unresolving pneumonia and determining the underlying ateology .
Time Frame: One year
Recurrent pneumonia is defined as two episodes of pneumonia in 1 year or three episodes over any time frame. Non resolving pneumonias are characterized by the persistence of symptoms and roentgenographic abnormalities for more than 1 month. The key step in evaluating the patient referred for recurrent or persistent pneumonia is to review the clinical and radiographic features of the episodes to determine if there is adequate documentation to proceed with treatment. After deciding that a patient has had a persistent episode of pneumonia or the requisite number of recurrent episodes of pneumonia (accompanied by radiographic evidence of pulmonary infiltrates), it is essential to classify the episodes into those involving single or multiple lobes. On the basis of this classification.
One year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Assiut University

Investigators

  • Study Director: Maher Mokhtar Ahmed, Professor, AssiutUniversity
  • Study Director: Ahlam Badawi Ali, Doctor, AssiutUniversity

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

January 1, 2025

Primary Completion (Estimated)

January 1, 2025

Study Completion (Estimated)

February 2, 2025

Study Registration Dates

First Submitted

September 7, 2024

First Submitted That Met QC Criteria

December 6, 2024

First Posted (Estimated)

December 10, 2024

Study Record Updates

Last Update Posted (Estimated)

December 10, 2024

Last Update Submitted That Met QC Criteria

December 6, 2024

Last Verified

December 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Atypical pneumonia

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Unresolving Pneumonia in Children

Clinical Trials on Laboratory as cbc crp

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahamas

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe